Speciation of metabolites of selenate in rats by HPLC-ICP-MS

Abstract

The metabolic pathway for and metabolites of selenium (Se) administered intravenously to rats in the form of selenate at a dose of 0.3 mg Se kg^–1 body weight were studied by speciating Se in the bloodstream, liver and urine by HPLC–inductively coupled argon plasma mass spectrometry. Selenate was not taken up by red blood cells (RBCs) and disappeared from the bloodstream much faster than selenite, without any change in its chemical form before it disappeared from the plasma. Selenium excreted into the urine after the administration of selenate showed different patterns from those of selenite in both amounts and chemical forms. With the selenate group, the concentration of Se in urine was highest at 0–6 h and the chemical species of Se was selenate at 0–6 h; thereafter a monomethylselenol-related Se compound (MMSe*) and trimethylselenonium ions (TMSe) appeared, selenate not being excreted after 6 h. On the other hand, in the selenite group, the concentration of Se peaked at 6–12 h, and the chemical species of Se were MMSe* and TMSe. Selenate was reduced in vitro on incubation in either a liver homogenate or supernatant fraction, although much more slowly than in the whole body. Selenate was not reduced by glutathione or dithiothreitol. The results suggest that in contrast to selenite, which is taken up by and reduced in RBCs, and then transferred to the liver, approximately 20% of the selenate administered to rats was excreted into the urine without any change in its chemical form with the present dose, and the major portion of selenate was taken up by the liver, reduced and then utilized for the synthesis of selenoproteins or excreted into the urine after being methylated.

References

1. R. Lobinski and M. Potin-Gautier, Analusis, 1998, 26, M21.
2. A. Makarov and J. Szpunar, Analusis, 1998, 26, M44.
3. K. T. Suzuki, Analusis, 1998, 26, M57.
4. K. T. Suzuki, Tohoku J. Exp. Med., 1996, 178, 27.
5. S. Yoneda and K. T. Suzuki, Toxicol. Appl. Pharmacol., 1997, 143, 274.
6. C. Sasakura and K. T. Suzuki, J. Inorg. Biochem., 1998, 71, 159.
7. C. D. Thomson and R. D. T. Stewart, Br. J. Nutr., 1973, 30, 139.
8. K. T. Suzuki, Y. Shiobara, M. Itoh and M. Ohmichi, Analyst, 1998, 123, 63.
9. Y. Shiobara and K. T. Suzuki, J. Chromatogr. B, 1998, 710, 49.
10. M. Itoh and K. T. Suzuki, Arch. Toxicol., 1997, 71, 461.
11. H. S. Hsieh and H. E. Ganther, Biochemistry, 1975, 14, 1632.
12. S. J. Fairweather-Tait, Eur. J. Clin. Nutr., 1997, 51, S20.
13. S. J. Fairweather-Tait, in Metal Ions in Biology and Medicine, ed. P. Collery, P. Bratter, V. Negretti de Bratter, L. Khasanova and J.-C. Etienne, John Libbey, Paris, 1998, pp. 211–217.
14. L. Shen, K. van Dyck, J. Luten and H. Deelstra, Biol. Trace Elem. Res., 1997, 58, 55.
15. C. Spyrou, M. Bjornstedt, S. Skog and A. Holmgren, Cancer Res., 1996, 56, 4407.
16. M. Sandholm, Acta Pharmacol. Toxicol., 1973, 33, 1.